The modern pandemic has ushered the Biotech, Pharmaceutical, and Medical Device industry into an era where clinical trials require accelerated timelines on unprecedented levels. As such, modern clinical data management teams are responding to the need for intelligent analytical data review by leveraging technological advancements and advanced centralized data management experts. This powerful combination yields...
December 8th – 9th , 2021 London, UK Booth TBD Visit Premier Research at Booth 36 at Outsourcing in Clinical Trials (OCT) UK & Ireland to discuss the common challenges and trends impacting the region such as COVID, steps for defining contractual relationships and getting the maximum from external providers, incentivizing good relationships with CROs...
December 7th – 8th , 2021 La Jolla, CA Booth 36 Visit Premier Research at Booth 36 at Outsourcing in Clinical Trials (OCT) Southern California to discuss the common challenges and trends impacting the region such as COVID, steps for defining contractual relationships and getting the maximum from external providers, incentivizing good relationships with CROs...
November 9th – 10th, 2021 Boston, MA Booth 69 Visit Premier Research at Booth 69 at Outsourcing in Clinical Trials (OCT) New England to discuss the common challenges and trends impacting the region such as COVID, steps for defining contractual relationships and getting the maximum from external providers, incentivizing good relationships with CROs and constructing...
Is Technology Replacing MEDDRA and WHODRUG Coding Specialists in Clinical Trials? All data generated in a clinical trial must be uniformly interpreted to ensure accurate results. Correct medical coding plays a critical role — and how that coding happens may be shifting. How is technology affecting the process of medical coding in clinical trials? Watch...
For a biotech company, sudden growth can come in many forms. When your company finds it necessary to scale quickly while still maintaining complete oversight over every aspect of your study, partnering with a functional service provider (FSP) may be an excellent solution. Complete control over your projects and data Under an FSP model, you...
A clinical hold from the U.S. Food and Drug Administration can significantly prolong the time and increase the cost of drug development, which is particularly concerning for emerging/small biotech and specialty pharma companies. In this blog, we discuss common reasons for clinical holds and provide useful tips for both avoiding and addressing them. Brief background...
Access our deep resource pool FSPs can drive down costs and make you even more agile We have created a flexible sourcing approach that gives operational teams the benefit of our clinical research expertise and access to our extensive resources. The advantages we offer can take many forms – from outsourcing to server hosting, from...
DURHAM, N.C., March 30, 2018 — Predicting the cost of clinical trials is a complex task, and more CROs are providing grant forecasting as a service to produce more accurate projections and give customers greater visibility. A grant forecasting expert from Premier Research will discuss new approaches to predicting trial costs in April at the...
Forecasting the cost of clinical drug and medical device trials has never been easy, and as trials become more complex, estimating (and re-estimating) these costs becomes even more challenging. Lack of accurate forecasts has serious schedule and cost implications. By impeding effective cash management, inaccurate projections can lead to disruptions and delays that cost sponsors...